Want to see IN:BALAMINES full AI Analyst Report?
Top Page
Balaji Amines Limited
(BALAMINES)
Select Model
Select Model
Rating:56Neutral
Price Target:
₹2,357.00
▲(3.28% Upside)
Action:Reiterated
Date:10/07/26
The score is driven primarily by mixed financial performance: a very strong, low-leverage balance sheet and continued profitability are offset by FY2026’s materially negative free cash flow and weaker cash conversion. Technically, the stock holds above key moving averages but lacks strong momentum due to a negative MACD. Valuation is a headwind given the high P/E and low dividend yield.
Positive Factors
Diversified specialty-chemical applications
Serving several downstream industries gives Balaji Amines a broad base of potential demand rather than reliance on one application. Its specialty amines and derivatives are embedded as intermediates in customer processes, supporting repeat industrial usage and a durable position across multiple end markets.
Negative Factors
Negative free cash flow
Negative free cash flow and weaker conversion indicate that reported profits are not currently translating efficiently into cash. If this persists, heavier reinvestment or working-capital needs could consume liquidity and reduce the funds available for expansion, dividends, or other capital allocation.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified specialty-chemical applications
Serving several downstream industries gives Balaji Amines a broad base of potential demand rather than reliance on one application. Its specialty amines and derivatives are embedded as intermediates in customer processes, supporting repeat industrial usage and a durable position across multiple end markets.
Read all positive factors
Balaji Amines Limited (BALAMINES) vs. iShares MSCI India ETF (INDA)
Market Cap
₹74.14B
Dividend Yield0.51%
Average Volume (3M)13.17K
Price to Earnings (P/E)34.1
Beta (1Y)0.98
Revenue Growth11.08%
EPS Growth34.10%
CountryIN
Employees1,266
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)63.28
Shares Outstanding32,401,000
10 Day Avg. Volume9,172
30 Day Avg. Volume13,171
Financial Highlights & Ratios
PEG Ratio3.07
Price to Book (P/B)1.60
Price to Sales (P/S)2.22
P/FCF Ratio-18.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)64.55
Revenue Forecast (FY)₹18.85B
Balaji Amines Limited Business Overview & Revenue Model
Company Description
Balaji Amines Limited, an Indian company, specializes in the production and global distribution of methylamines, ethylamines, their associated derivatives, alongside a diverse portfolio of specialty chemicals and pharmaceutical excipients. The fir...
How the Company Makes Money
Balaji Amines primarily makes money by manufacturing and selling chemical products—mainly aliphatic amines and amine derivatives—to industrial customers. Its core revenue stream is product sales, where earnings are driven by (a) sales volumes to d...
Balaji Amines Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
78
Positive
Cash Flow
45
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.23B | 14.25B | 13.97B | 16.08B | 23.38B | 23.20B |
| Gross Profit | 6.07B | 4.88B | 4.88B | 3.50B | 8.39B | 8.57B |
| EBITDA | 3.52B | 2.92B | 2.65B | 3.53B | 6.24B | 6.36B |
| Net Income | 2.04B | 1.67B | 1.58B | 2.05B | 3.26B | 3.68B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 27.43B | 22.52B | 21.46B | 19.63B | 18.75B |
| Cash, Cash Equivalents and Short-Term Investments | 2.70B | 2.71B | 3.50B | 3.31B | 3.09B | 515.37M |
| Total Debt | 0.00 | 1.33B | 110.27M | 196.97M | 575.74M | 1.01B |
| Total Liabilities | -21.52B | 5.91B | 2.34B | 2.53B | 2.65B | 5.60B |
| Stockholders Equity | 21.52B | 19.76B | 18.45B | 17.22B | 15.54B | 12.50B |
Cash Flow | ||||||
| Free Cash Flow | -1.62B | -1.74B | 874.82M | 704.14M | 2.62B | 842.07M |
| Operating Cash Flow | 222.05M | 1.96B | 2.73B | 3.34B | 3.82B | 2.32B |
| Investing Cash Flow | -1.15B | -3.58B | -1.61B | -1.64B | -1.86B | -1.47B |
| Financing Cash Flow | -169.00M | 865.75M | -447.73M | -749.66M | -812.33M | -565.13M |
Balaji Amines Limited Technical Analysis
Positive
2282.15
Price Trends
2206.38
Negative
2147.88
Positive
1645.26
Positive
Market Momentum
-35.54
Positive
48.16
Neutral
48.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BALAMINES, the sentiment is Positive. The current price of 2282.15 is above the 20-day moving average (MA) of 2192.36, above the 50-day MA of 2206.38, and above the 200-day MA of 1645.26, indicating a neutral trend. The MACD of -35.54 indicates Positive momentum. The RSI at 48.16 is Neutral, neither overbought nor oversold. The STOCH value of 48.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BALAMINES.
Balaji Amines Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹100.15B | 43.58 | ― | 0.52% | 5.11% | 20.64% | |
65 Neutral | ₹10.35B | 24.62 | ― | 0.29% | -12.40% | -3.04% | |
56 Neutral | ₹74.14B | 34.07 | ― | 0.51% | 11.08% | 34.10% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ₹133.23B | 75.75 | ― | 0.13% | 51.77% | 36.90% | |
53 Neutral | ₹102.55B | 32.88 | ― | 0.78% | 10.96% | 11.16% | |
50 Neutral | ₹52.46B | 42.02 | ― | 0.16% | 5.47% | 24.88% |
* General Sector Average
IN:BALAMINES
Balaji Amines Limited
2,158.85
786.60
57.32%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,918.35
77.44
4.21%
IN:AMNPLST
Amines & Plasticizers Ltd.
172.10
-35.68
-17.17%
IN:ANURAS
Anupam Rasayan India Ltd.
1,166.25
59.66
5.39%
IN:JUBLINGREA
Jubilant Ingrevia Ltd.
641.30
-8.64
-1.33%
IN:LXCHEM
Laxmi Organic Industries Ltd.
190.25
-14.90
-7.26%
Balaji Amines Limited Corporate Events
Balaji Amines Sees Bank Loan Credit Rating Withdrawn After Clearing Dues
Sep 12, 2026
Balaji Amines Limited has announced that India Ratings and Research has withdrawn the credit rating assigned to its bank loan facilities after the company obtained No Dues Certificates from all lenders. The withdrawal follows the company’s r...
Balaji Amines Clears All Resolutions at 38th AGM, Announces Dividend
Jul 13, 2026
Balaji Amines Limited, a listed chemicals manufacturer known for aliphatic amines and specialty intermediates for pharma and agro industries, continues to operate within India’s regulated capital markets framework. Its governance practices, ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.